trial · primary record
Sirolimus
Tuberous Sclerosis Complex
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 64 |
| Primary completion | 2028-06-30 |
| Primary endpoint | Efficacy -- time to seizure onset |
| Registry ID | NCT05104983 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:50.412Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05104983
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.